| NanoVelcro rare-cell assays for detection and characterization of circulating tumor cells YJ Jan, JF Chen, Y Zhu, YT Lu, SH Chen, H Chung, M Smalley, ... Advanced drug delivery reviews 125, 78-93, 2018 | 121 | 2018 |
| Posterior reversible encephalopathy syndrome (PRES) as a neurological association in severe Covid-19 L Kishfy, M Casasola, P Banankhah, A Parvez, YJ Jan, AM Shenoy, ... Journal of the neurological sciences 414, 116943, 2020 | 101 | 2020 |
| Bio-inspired nanovilli chips for enhanced capture of tumor-derived extracellular vesicles: toward non-invasive detection of gene alterations in non-small cell lung cancer J Dong, RY Zhang, N Sun, M Smalley, Z Wu, A Zhou, SJ Chou, YJ Jan, ... ACS applied materials & interfaces 11 (15), 13973-13983, 2019 | 84 | 2019 |
| Imprinted NanoVelcro microchips for isolation and characterization of circulating fetal trophoblasts: toward noninvasive prenatal diagnostics S Hou, JF Chen, M Song, Y Zhu, YJ Jan, SH Chen, TH Weng, DA Ling, ... ACS nano 11 (8), 8167-8177, 2017 | 84 | 2017 |
| Glycan stimulation enables purification of prostate cancer circulating tumor cells on PEDOT NanoVelcro chips for RNA biomarker detection MY Shen, JF Chen, CH Luo, S Lee, CH Li, YL Yang, YH Tsai, BC Ho, ... Advanced healthcare materials 7 (3), 1700701, 2018 | 51 | 2018 |
| Covalent chemistry on nanostructured substrates enables noninvasive quantification of gene rearrangements in circulating tumor cells J Dong, YJ Jan, J Cheng, RY Zhang, M Meng, M Smalley, PJ Chen, ... Science advances 5 (7), eaav9186, 2019 | 49 | 2019 |
| Prostate cancer extracellular vesicle digital scoring assay–a rapid noninvasive approach for quantification of disease-relevant mRNAs JJ Wang, N Sun, YT Lee, M Kim, T Vagner, K Rohena-Rivera, Z Wang, ... Nano Today 48, 101746, 2023 | 29 | 2023 |
| A circulating tumor cell-RNA assay for assessment of androgen receptor signaling inhibitor sensitivity in metastatic castration-resistant prostate cancer YJ Jan, J Yoon, JF Chen, PC Teng, N Yao, S Cheng, A Lozano, GCY Chu, ... Theranostics 9 (10), 2812, 2019 | 29 | 2019 |
| Noninvasive prenatal diagnostics: recent developments using circulating fetal nucleated cells PJ Chen, PC Teng, Y Zhu, YJ Jan, M Smalley, Y Afshar, LC Chen, ... Current obstetrics and gynecology reports 8 (1), 1-8, 2019 | 20 | 2019 |
| Structure and function analysis in circulating tumor cells: using nanotechnology to study nuclear size in prostate cancer N Yao, YJ Jan, S Cheng, JF Chen, LWK Chung, HR Tseng, EM Posadas American journal of clinical and experimental urology 6 (2), 43, 2018 | 10 | 2018 |
| Body mass index and type 2 diabetes mellitus as metabolic determinants of immune checkpoint inhibitors response in melanoma YJA Jan, CH Chiang, S Osataphan, AR Lawless, KL Reynolds, ... Journal for Immunotherapy of Cancer 12 (11), e009769, 2024 | 5 | 2024 |
| Loss of CDCP1 triggers FAK activation in detached prostate cancer cells SG Pollan, PC Teng, YJ Jan, J Livingstone, C Huang, M Kim, J Mariscal, ... American journal of clinical and experimental urology 9 (4), 350, 2021 | 5 | 2021 |
| Association between higher glucose levels and reduced survival in patients with non-small cell lung cancer treated with immune checkpoint inhibitors S Osataphan, M Awidi, YJ Jan, K Gunturu, S Sundararaman, H Viray, ... Lung Cancer 198, 108023, 2024 | 3 | 2024 |
| Obesity, dyslipidemia, and diabetes as determinants of response to immune checkpoint inhibitors in non-small cell lung cancer. SA Osataphan, M Awidi, YJ Jan, S Sundararaman, H Viray, ... Journal of Clinical Oncology 41 (16_suppl), e21125-e21125, 2023 | 2 | 2023 |
| Imprinted NanoVelcro Microchips for Isolation and Characterization of Circulating Fetal Trophoblasts: Toward Noninvasive Prenatal Diagnostics (vol 11, pg 8167, 2017) S Hou, JF Chen, M Song, Y Zhu, YJ Jan, SH Chen, TH Weng, DA Ling, ... ACS NANO 11 (12), 12863-12863, 2017 | 2 | 2017 |
| 541 Diabetes and glucose level as metabolic determinants of immune checkpoint inhibitors response in melanoma YJA Jan, S Osataphan, CH Chiang, K Reynolds, R Sullivan Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | 1 | 2023 |
| Barriers to optimal breast cancer screening modalities for high-risk patients in the primary care setting YJ Jan, PB Lam Cancer Research 83 (7_Supplement), 3029-3029, 2023 | 1 | 2023 |
| Obesity diabetes and dyslipidemia as determinants of immune checkpoint inhibitors response in non-small cell lung cancer. M Awidi, S Osataphan, YJ Jan, E Frankenberger, M Mariano, KA Stafford, ... Journal of Clinical Oncology 40 (16_suppl), e21104-e21104, 2022 | 1 | 2022 |
| Nuclear size of circulating tumor cells in advanced prostate cancer to reveal a potential biomarker for clinical outcomes and androgen receptor indifference. JJ Wang, KA Cavassani, PC Teng, JF Chen, YJ Jan, GCY Chu, YT Lee, ... Journal of Clinical Oncology 39 (6_suppl), 167-167, 2021 | 1 | 2021 |
| Development of a circulating tumor cell-based RNA classifier for patients with castration-resistant prostate cancer: CTC-PCS/PAM50. PC Teng, YJ Jan, M Kim, JF Chen, J Yoon, JJ Wang, PJ Chen, N Yao, ... Journal of Clinical Oncology 38 (15_suppl), e17509-e17509, 2020 | 1 | 2020 |
Hsian-Rong Tseng (曾憲榮)Professor, Department of Molecular and Medical Pharmacology, UCLAVerified email at mednet.ucla.edu
